McDermott Will & Emery advised Tissium on a Series D financing round. Tissium, a private medtech company specializing in the development of programmable biomorphic polymers for...
Tissium’s EUR50 Million Series D Fundraising
Tissium’s €50 Million Series C Financing Round
Goodwin Procter advised Cathay Health on the deal. TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, has closed a Series C round...